Esperion Therapeutics, Inc. (NASDAQ:ESPR) has 195 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 17,852,427 | 170,226 | 0.96% | $48,915,650.00 |
| WASATCH ADVISORS LP | 31 Mar, 2026 | 15,768,897 | 6,323,138 | 66.94% | $43,206,778.00 |
| Two Seas Capital LP | 31 Mar, 2026 | 11,394,833 | -507,688 | -4.27% | $31,221,842.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 10,570,300 | 4,604,802 | 77.19% | $28,962,622.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 10,433,760 | 10,433,760 | 0.00% | $28,588,502.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 9,458,779 | 4,716,697 | 99.46% | $25,917,054.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 7,075,083 | 1,603,472 | 29.31% | $19,385,727.00 |
| State Street Corp | 31 Mar, 2026 | 7,055,794 | 1,125,498 | 18.98% | $19,332,876.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 6,540,785 | -362,698 | -5.25% | $17,921,751.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,955,739 | 218,088 | 3.80% | $16,322,581.00 |
| AIGH Capital Management LLC | 31 Mar, 2026 | 4,400,000 | 400,000 | 10.00% | $12,056,000.00 |
| UBS Group AG | 31 Mar, 2026 | 4,291,711 | 3,978,358 | 1,269.61% | $11,759,289.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 3,930,125 | 3,930,125 | 0.00% | $10,768,543.00 |
| PenderFund Capital Management Ltd. | 31 Mar, 2026 | 3,891,926 | -500,000 | -11.38% | $10,663,877.00 |
| Nuveen, LLC | 31 Mar, 2026 | 3,613,709 | 1,596 | 0.04% | $9,901,563.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 3,532,563 | 3,532,563 | 0.00% | $9,679,223.00 |
| Privium Fund Management B.V. | 31 Mar, 2026 | 3,299,441 | 3,299,441 | 0.00% | $9,040,468.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,735,644 | -778,583 | -22.16% | $7,495,664.00 |
| ROYCE & ASSOCIATES LP | 31 Mar, 2026 | 2,626,995 | -974,528 | -27.06% | $7,197,966.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 2,410,454 | -3,285,978 | -57.68% | $6,604,644.00 |